Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with <sup>131</sup>I-omburtamab for leptomeningeal disease.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01127-0
- By:
- Publication type:
- Article